WFH Advocates for Hemophilia Care Access at WHO EMRO Meeting in Cairo
World Federation of Hemophilia / Fédération mondiale de l’hémophilie posted on LinkedIn:
”During the 72nd Session of the WHO Regional Committee for the Eastern Mediterranean in Cairo, Egypt, WFH Regional Manager Rana Saifi delivered a statement advocating for the inclusion of hemophilia and other Bleeding Disorders in the WHO EMRO flagship initiative to expand access to quality medical products in the region.
This aligns with the recent WHO 2025 Essential Medicines List updates, a critical step forward that requires concrete regional and national action to ensure access to lifesaving treatments.
Saifi also voiced WFH’s strong support for a WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Inherited Bleeding Disorders, proposed for discussion at the 158th session of the WHO Executive Board and backed by several Member States including Armenia, Morocco, with support from Egypt, Nepal and Sri Lanka.
Read the full statement here.”
Stay updated with Hemostasis Today.
-
Mar 6, 2026, 11:49Love-Preet Kalra: Honored to Receive The Robert Wartenberg Award 2026
-
Mar 6, 2026, 11:43Matthew D. Neal: Turning Platelet Desert Into a Lifesaving Oasis at WTA 2026
-
Mar 6, 2026, 11:35Intensive Clotting Factor Prophylaxis Does Not Prevent Severe PPH in VWD – JTH
-
Mar 6, 2026, 09:15Reza Bavarsad Shahripour: When the Ophthalmic Artery Tells the Story of the Carotid
-
Mar 6, 2026, 09:13Louise St. Germain Bannon: Advancing Thrombosis and Hemostasis Through a Global Community
-
Mar 6, 2026, 09:06Kathleen Freson: Protein C Deficiency as a Genetic Modifier of Severe Haemophilia A
-
Mar 5, 2026, 17:48Estelle Carminita։ What If the Origin of Platelet Dysfunction Starts in the Bone Marrow
-
Mar 5, 2026, 17:43Pierre Sabouret: The Best Antithrombotic Strategy in Patients with Atherosclerotic Stroke and AF
-
Mar 5, 2026, 17:37John Abraham։ The Role of Diagnostic Splenectomy in Unexplained Splenomegaly